Public Applauds Duty Exemption on Cancer Drug Materials
ISLAMABAD — The Pakistani government has removed customs duty on raw materials for local cancer drug production. This significant policy change has garnered widespread applause from patients, pharmacists, and healthcare stakeholders. Anticipated benefits include lower treatment costs and improved access to essential medications across the nation. Enhancing Medication Affordability This removal of financial barriers by the government is aimed at increasing the availability of life-saving drugs. Announced last Friday, the policy is poised to greatly benefit the healthcare sector. It will substantially reduce overall expenses, making medications more affordable for patients nationwide. Optimism from Stakeholders Various stakeholders have expressed optimism regarding the duty exemption’s positive impact. The policy facilitates both the production and distribution of critical medicines, decreasing financial burdens on patients facing high treatment costs. This move promises significant benefits for communities across Pakistan.









